The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Mydriatic Eyedrops Market Research Report 2025
Synopsis
The global Mydriatic Eyedrops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Mydriatic Eyedrops, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mydriatic Eyedrops.
Report Scope
The Mydriatic Eyedrops market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Mydriatic Eyedrops market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mydriatic Eyedrops manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis AG
Allergan, Inc.
Meda Pharmaceuticals Inc
Bausch & Lomb Inc
Cigna
Similasan Corporation
Visine
Alcon
Viva Opti-Free
Bausch & Lomb
Systane
Rite Aid
Walgreens
Staples
Clear eyes
Segment by Type
Atropine
Homatropine
Dolly
Others
Segment by Application
Adult
Children
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Mydriatic Eyedrops manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Mydriatic Eyedrops in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Mydriatic Eyedrops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Mydriatic Eyedrops, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mydriatic Eyedrops.
Report Scope
The Mydriatic Eyedrops market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Mydriatic Eyedrops market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mydriatic Eyedrops manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis AG
Allergan, Inc.
Meda Pharmaceuticals Inc
Bausch & Lomb Inc
Cigna
Similasan Corporation
Visine
Alcon
Viva Opti-Free
Bausch & Lomb
Systane
Rite Aid
Walgreens
Staples
Clear eyes
Segment by Type
Atropine
Homatropine
Dolly
Others
Segment by Application
Adult
Children
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Mydriatic Eyedrops manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Mydriatic Eyedrops in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Mydriatic Eyedrops Market Overview
1.1 Product Overview and Scope of Mydriatic Eyedrops
1.2 Mydriatic Eyedrops Segment by Type
1.2.1 Global Mydriatic Eyedrops Market Value Comparison by Type (2024-2030)
1.2.2 Atropine
1.2.3 Homatropine
1.2.4 Dolly
1.2.5 Others
1.3 Mydriatic Eyedrops Segment by Application
1.3.1 Global Mydriatic Eyedrops Market Value by Application: (2024-2030)
1.3.2 Adult
1.3.3 Children
1.4 Global Mydriatic Eyedrops Market Size Estimates and Forecasts
1.4.1 Global Mydriatic Eyedrops Revenue 2019-2030
1.4.2 Global Mydriatic Eyedrops Sales 2019-2030
1.4.3 Global Mydriatic Eyedrops Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Mydriatic Eyedrops Market Competition by Manufacturers
2.1 Global Mydriatic Eyedrops Sales Market Share by Manufacturers (2019-2024)
2.2 Global Mydriatic Eyedrops Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Mydriatic Eyedrops Average Price by Manufacturers (2019-2024)
2.4 Global Mydriatic Eyedrops Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Mydriatic Eyedrops, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Mydriatic Eyedrops, Product Type & Application
2.7 Mydriatic Eyedrops Market Competitive Situation and Trends
2.7.1 Mydriatic Eyedrops Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Mydriatic Eyedrops Players Market Share by Revenue
2.7.3 Global Mydriatic Eyedrops Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Mydriatic Eyedrops Retrospective Market Scenario by Region
3.1 Global Mydriatic Eyedrops Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Mydriatic Eyedrops Global Mydriatic Eyedrops Sales by Region: 2019-2030
3.2.1 Global Mydriatic Eyedrops Sales by Region: 2019-2024
3.2.2 Global Mydriatic Eyedrops Sales by Region: 2025-2030
3.3 Global Mydriatic Eyedrops Global Mydriatic Eyedrops Revenue by Region: 2019-2030
3.3.1 Global Mydriatic Eyedrops Revenue by Region: 2019-2024
3.3.2 Global Mydriatic Eyedrops Revenue by Region: 2025-2030
3.4 North America Mydriatic Eyedrops Market Facts & Figures by Country
3.4.1 North America Mydriatic Eyedrops Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Mydriatic Eyedrops Sales by Country (2019-2030)
3.4.3 North America Mydriatic Eyedrops Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Mydriatic Eyedrops Market Facts & Figures by Country
3.5.1 Europe Mydriatic Eyedrops Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Mydriatic Eyedrops Sales by Country (2019-2030)
3.5.3 Europe Mydriatic Eyedrops Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Mydriatic Eyedrops Market Facts & Figures by Country
3.6.1 Asia Pacific Mydriatic Eyedrops Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Mydriatic Eyedrops Sales by Country (2019-2030)
3.6.3 Asia Pacific Mydriatic Eyedrops Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Mydriatic Eyedrops Market Facts & Figures by Country
3.7.1 Latin America Mydriatic Eyedrops Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Mydriatic Eyedrops Sales by Country (2019-2030)
3.7.3 Latin America Mydriatic Eyedrops Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Mydriatic Eyedrops Market Facts & Figures by Country
3.8.1 Middle East and Africa Mydriatic Eyedrops Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Mydriatic Eyedrops Sales by Country (2019-2030)
3.8.3 Middle East and Africa Mydriatic Eyedrops Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Mydriatic Eyedrops Sales by Type (2019-2030)
4.1.1 Global Mydriatic Eyedrops Sales by Type (2019-2024)
4.1.2 Global Mydriatic Eyedrops Sales by Type (2025-2030)
4.1.3 Global Mydriatic Eyedrops Sales Market Share by Type (2019-2030)
4.2 Global Mydriatic Eyedrops Revenue by Type (2019-2030)
4.2.1 Global Mydriatic Eyedrops Revenue by Type (2019-2024)
4.2.2 Global Mydriatic Eyedrops Revenue by Type (2025-2030)
4.2.3 Global Mydriatic Eyedrops Revenue Market Share by Type (2019-2030)
4.3 Global Mydriatic Eyedrops Price by Type (2019-2030)
5 Segment by Application
5.1 Global Mydriatic Eyedrops Sales by Application (2019-2030)
5.1.1 Global Mydriatic Eyedrops Sales by Application (2019-2024)
5.1.2 Global Mydriatic Eyedrops Sales by Application (2025-2030)
5.1.3 Global Mydriatic Eyedrops Sales Market Share by Application (2019-2030)
5.2 Global Mydriatic Eyedrops Revenue by Application (2019-2030)
5.2.1 Global Mydriatic Eyedrops Revenue by Application (2019-2024)
5.2.2 Global Mydriatic Eyedrops Revenue by Application (2025-2030)
5.2.3 Global Mydriatic Eyedrops Revenue Market Share by Application (2019-2030)
5.3 Global Mydriatic Eyedrops Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Novartis AG
6.1.1 Novartis AG Corporation Information
6.1.2 Novartis AG Description and Business Overview
6.1.3 Novartis AG Mydriatic Eyedrops Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novartis AG Mydriatic Eyedrops Product Portfolio
6.1.5 Novartis AG Recent Developments/Updates
6.2 Allergan, Inc.
6.2.1 Allergan, Inc. Corporation Information
6.2.2 Allergan, Inc. Description and Business Overview
6.2.3 Allergan, Inc. Mydriatic Eyedrops Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Allergan, Inc. Mydriatic Eyedrops Product Portfolio
6.2.5 Allergan, Inc. Recent Developments/Updates
6.3 Meda Pharmaceuticals Inc
6.3.1 Meda Pharmaceuticals Inc Corporation Information
6.3.2 Meda Pharmaceuticals Inc Description and Business Overview
6.3.3 Meda Pharmaceuticals Inc Mydriatic Eyedrops Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Meda Pharmaceuticals Inc Mydriatic Eyedrops Product Portfolio
6.3.5 Meda Pharmaceuticals Inc Recent Developments/Updates
6.4 Bausch & Lomb Inc
6.4.1 Bausch & Lomb Inc Corporation Information
6.4.2 Bausch & Lomb Inc Description and Business Overview
6.4.3 Bausch & Lomb Inc Mydriatic Eyedrops Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bausch & Lomb Inc Mydriatic Eyedrops Product Portfolio
6.4.5 Bausch & Lomb Inc Recent Developments/Updates
6.5 Cigna
6.5.1 Cigna Corporation Information
6.5.2 Cigna Description and Business Overview
6.5.3 Cigna Mydriatic Eyedrops Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Cigna Mydriatic Eyedrops Product Portfolio
6.5.5 Cigna Recent Developments/Updates
6.6 Similasan Corporation
6.6.1 Similasan Corporation Corporation Information
6.6.2 Similasan Corporation Description and Business Overview
6.6.3 Similasan Corporation Mydriatic Eyedrops Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Similasan Corporation Mydriatic Eyedrops Product Portfolio
6.6.5 Similasan Corporation Recent Developments/Updates
6.7 Visine
6.6.1 Visine Corporation Information
6.6.2 Visine Description and Business Overview
6.6.3 Visine Mydriatic Eyedrops Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Visine Mydriatic Eyedrops Product Portfolio
6.7.5 Visine Recent Developments/Updates
6.8 Alcon
6.8.1 Alcon Corporation Information
6.8.2 Alcon Description and Business Overview
6.8.3 Alcon Mydriatic Eyedrops Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Alcon Mydriatic Eyedrops Product Portfolio
6.8.5 Alcon Recent Developments/Updates
6.9 Viva Opti-Free
6.9.1 Viva Opti-Free Corporation Information
6.9.2 Viva Opti-Free Description and Business Overview
6.9.3 Viva Opti-Free Mydriatic Eyedrops Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Viva Opti-Free Mydriatic Eyedrops Product Portfolio
6.9.5 Viva Opti-Free Recent Developments/Updates
6.10 Bausch & Lomb
6.10.1 Bausch & Lomb Corporation Information
6.10.2 Bausch & Lomb Description and Business Overview
6.10.3 Bausch & Lomb Mydriatic Eyedrops Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Bausch & Lomb Mydriatic Eyedrops Product Portfolio
6.10.5 Bausch & Lomb Recent Developments/Updates
6.11 Systane
6.11.1 Systane Corporation Information
6.11.2 Systane Mydriatic Eyedrops Description and Business Overview
6.11.3 Systane Mydriatic Eyedrops Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Systane Mydriatic Eyedrops Product Portfolio
6.11.5 Systane Recent Developments/Updates
6.12 Rite Aid
6.12.1 Rite Aid Corporation Information
6.12.2 Rite Aid Mydriatic Eyedrops Description and Business Overview
6.12.3 Rite Aid Mydriatic Eyedrops Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Rite Aid Mydriatic Eyedrops Product Portfolio
6.12.5 Rite Aid Recent Developments/Updates
6.13 Walgreens
6.13.1 Walgreens Corporation Information
6.13.2 Walgreens Mydriatic Eyedrops Description and Business Overview
6.13.3 Walgreens Mydriatic Eyedrops Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Walgreens Mydriatic Eyedrops Product Portfolio
6.13.5 Walgreens Recent Developments/Updates
6.14 Staples
6.14.1 Staples Corporation Information
6.14.2 Staples Mydriatic Eyedrops Description and Business Overview
6.14.3 Staples Mydriatic Eyedrops Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Staples Mydriatic Eyedrops Product Portfolio
6.14.5 Staples Recent Developments/Updates
6.15 Clear eyes
6.15.1 Clear eyes Corporation Information
6.15.2 Clear eyes Mydriatic Eyedrops Description and Business Overview
6.15.3 Clear eyes Mydriatic Eyedrops Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Clear eyes Mydriatic Eyedrops Product Portfolio
6.15.5 Clear eyes Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Mydriatic Eyedrops Industry Chain Analysis
7.2 Mydriatic Eyedrops Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Mydriatic Eyedrops Production Mode & Process
7.4 Mydriatic Eyedrops Sales and Marketing
7.4.1 Mydriatic Eyedrops Sales Channels
7.4.2 Mydriatic Eyedrops Distributors
7.5 Mydriatic Eyedrops Customers
8 Mydriatic Eyedrops Market Dynamics
8.1 Mydriatic Eyedrops Industry Trends
8.2 Mydriatic Eyedrops Market Drivers
8.3 Mydriatic Eyedrops Market Challenges
8.4 Mydriatic Eyedrops Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Mydriatic Eyedrops Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Mydriatic Eyedrops Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Mydriatic Eyedrops Market Competitive Situation by Manufacturers in 2023
Table 4. Global Mydriatic Eyedrops Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Mydriatic Eyedrops Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Mydriatic Eyedrops Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Mydriatic Eyedrops Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Mydriatic Eyedrops Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Mydriatic Eyedrops, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Mydriatic Eyedrops, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Mydriatic Eyedrops, Product Type & Application
Table 12. Global Key Manufacturers of Mydriatic Eyedrops, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Mydriatic Eyedrops by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mydriatic Eyedrops as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Mydriatic Eyedrops Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Mydriatic Eyedrops Sales by Region (2019-2024) & (K Units)
Table 18. Global Mydriatic Eyedrops Sales Market Share by Region (2019-2024)
Table 19. Global Mydriatic Eyedrops Sales by Region (2025-2030) & (K Units)
Table 20. Global Mydriatic Eyedrops Sales Market Share by Region (2025-2030)
Table 21. Global Mydriatic Eyedrops Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Mydriatic Eyedrops Revenue Market Share by Region (2019-2024)
Table 23. Global Mydriatic Eyedrops Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Mydriatic Eyedrops Revenue Market Share by Region (2025-2030)
Table 25. North America Mydriatic Eyedrops Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Mydriatic Eyedrops Sales by Country (2019-2024) & (K Units)
Table 27. North America Mydriatic Eyedrops Sales by Country (2025-2030) & (K Units)
Table 28. North America Mydriatic Eyedrops Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Mydriatic Eyedrops Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Mydriatic Eyedrops Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Mydriatic Eyedrops Sales by Country (2019-2024) & (K Units)
Table 32. Europe Mydriatic Eyedrops Sales by Country (2025-2030) & (K Units)
Table 33. Europe Mydriatic Eyedrops Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Mydriatic Eyedrops Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Mydriatic Eyedrops Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Mydriatic Eyedrops Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Mydriatic Eyedrops Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Mydriatic Eyedrops Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Mydriatic Eyedrops Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Mydriatic Eyedrops Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Mydriatic Eyedrops Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Mydriatic Eyedrops Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Mydriatic Eyedrops Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Mydriatic Eyedrops Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Mydriatic Eyedrops Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Mydriatic Eyedrops Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Mydriatic Eyedrops Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Mydriatic Eyedrops Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Mydriatic Eyedrops Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Mydriatic Eyedrops Sales (K Units) by Type (2019-2024)
Table 51. Global Mydriatic Eyedrops Sales (K Units) by Type (2025-2030)
Table 52. Global Mydriatic Eyedrops Sales Market Share by Type (2019-2024)
Table 53. Global Mydriatic Eyedrops Sales Market Share by Type (2025-2030)
Table 54. Global Mydriatic Eyedrops Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Mydriatic Eyedrops Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Mydriatic Eyedrops Revenue Market Share by Type (2019-2024)
Table 57. Global Mydriatic Eyedrops Revenue Market Share by Type (2025-2030)
Table 58. Global Mydriatic Eyedrops Price (USD/Unit) by Type (2019-2024)
Table 59. Global Mydriatic Eyedrops Price (USD/Unit) by Type (2025-2030)
Table 60. Global Mydriatic Eyedrops Sales (K Units) by Application (2019-2024)
Table 61. Global Mydriatic Eyedrops Sales (K Units) by Application (2025-2030)
Table 62. Global Mydriatic Eyedrops Sales Market Share by Application (2019-2024)
Table 63. Global Mydriatic Eyedrops Sales Market Share by Application (2025-2030)
Table 64. Global Mydriatic Eyedrops Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Mydriatic Eyedrops Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Mydriatic Eyedrops Revenue Market Share by Application (2019-2024)
Table 67. Global Mydriatic Eyedrops Revenue Market Share by Application (2025-2030)
Table 68. Global Mydriatic Eyedrops Price (USD/Unit) by Application (2019-2024)
Table 69. Global Mydriatic Eyedrops Price (USD/Unit) by Application (2025-2030)
Table 70. Novartis AG Corporation Information
Table 71. Novartis AG Description and Business Overview
Table 72. Novartis AG Mydriatic Eyedrops Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Novartis AG Mydriatic Eyedrops Product
Table 74. Novartis AG Recent Developments/Updates
Table 75. Allergan, Inc. Corporation Information
Table 76. Allergan, Inc. Description and Business Overview
Table 77. Allergan, Inc. Mydriatic Eyedrops Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Allergan, Inc. Mydriatic Eyedrops Product
Table 79. Allergan, Inc. Recent Developments/Updates
Table 80. Meda Pharmaceuticals Inc Corporation Information
Table 81. Meda Pharmaceuticals Inc Description and Business Overview
Table 82. Meda Pharmaceuticals Inc Mydriatic Eyedrops Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Meda Pharmaceuticals Inc Mydriatic Eyedrops Product
Table 84. Meda Pharmaceuticals Inc Recent Developments/Updates
Table 85. Bausch & Lomb Inc Corporation Information
Table 86. Bausch & Lomb Inc Description and Business Overview
Table 87. Bausch & Lomb Inc Mydriatic Eyedrops Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Bausch & Lomb Inc Mydriatic Eyedrops Product
Table 89. Bausch & Lomb Inc Recent Developments/Updates
Table 90. Cigna Corporation Information
Table 91. Cigna Description and Business Overview
Table 92. Cigna Mydriatic Eyedrops Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Cigna Mydriatic Eyedrops Product
Table 94. Cigna Recent Developments/Updates
Table 95. Similasan Corporation Corporation Information
Table 96. Similasan Corporation Description and Business Overview
Table 97. Similasan Corporation Mydriatic Eyedrops Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Similasan Corporation Mydriatic Eyedrops Product
Table 99. Similasan Corporation Recent Developments/Updates
Table 100. Visine Corporation Information
Table 101. Visine Description and Business Overview
Table 102. Visine Mydriatic Eyedrops Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Visine Mydriatic Eyedrops Product
Table 104. Visine Recent Developments/Updates
Table 105. Alcon Corporation Information
Table 106. Alcon Description and Business Overview
Table 107. Alcon Mydriatic Eyedrops Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Alcon Mydriatic Eyedrops Product
Table 109. Alcon Recent Developments/Updates
Table 110. Viva Opti-Free Corporation Information
Table 111. Viva Opti-Free Description and Business Overview
Table 112. Viva Opti-Free Mydriatic Eyedrops Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Viva Opti-Free Mydriatic Eyedrops Product
Table 114. Viva Opti-Free Recent Developments/Updates
Table 115. Bausch & Lomb Corporation Information
Table 116. Bausch & Lomb Description and Business Overview
Table 117. Bausch & Lomb Mydriatic Eyedrops Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Bausch & Lomb Mydriatic Eyedrops Product
Table 119. Bausch & Lomb Recent Developments/Updates
Table 120. Systane Corporation Information
Table 121. Systane Description and Business Overview
Table 122. Systane Mydriatic Eyedrops Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. Systane Mydriatic Eyedrops Product
Table 124. Systane Recent Developments/Updates
Table 125. Rite Aid Corporation Information
Table 126. Rite Aid Description and Business Overview
Table 127. Rite Aid Mydriatic Eyedrops Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. Rite Aid Mydriatic Eyedrops Product
Table 129. Rite Aid Recent Developments/Updates
Table 130. Walgreens Corporation Information
Table 131. Walgreens Description and Business Overview
Table 132. Walgreens Mydriatic Eyedrops Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 133. Walgreens Mydriatic Eyedrops Product
Table 134. Walgreens Recent Developments/Updates
Table 135. Staples Corporation Information
Table 136. Staples Description and Business Overview
Table 137. Staples Mydriatic Eyedrops Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 138. Staples Mydriatic Eyedrops Product
Table 139. Staples Recent Developments/Updates
Table 140. Clear eyes Corporation Information
Table 141. Clear eyes Description and Business Overview
Table 142. Clear eyes Mydriatic Eyedrops Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 143. Clear eyes Mydriatic Eyedrops Product
Table 144. Clear eyes Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Mydriatic Eyedrops Distributors List
Table 148. Mydriatic Eyedrops Customers List
Table 149. Mydriatic Eyedrops Market Trends
Table 150. Mydriatic Eyedrops Market Drivers
Table 151. Mydriatic Eyedrops Market Challenges
Table 152. Mydriatic Eyedrops Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Mydriatic Eyedrops
Figure 2. Global Mydriatic Eyedrops Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Mydriatic Eyedrops Market Share by Type in 2023 & 2030
Figure 4. Atropine Product Picture
Figure 5. Homatropine Product Picture
Figure 6. Dolly Product Picture
Figure 7. Others Product Picture
Figure 8. Global Mydriatic Eyedrops Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Mydriatic Eyedrops Market Share by Application in 2023 & 2030
Figure 10. Adult
Figure 11. Children
Figure 12. Global Mydriatic Eyedrops Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Mydriatic Eyedrops Market Size (2019-2030) & (US$ Million)
Figure 14. Global Mydriatic Eyedrops Sales (2019-2030) & (K Units)
Figure 15. Global Mydriatic Eyedrops Average Price (USD/Unit) & (2019-2030)
Figure 16. Mydriatic Eyedrops Report Years Considered
Figure 17. Mydriatic Eyedrops Sales Share by Manufacturers in 2023
Figure 18. Global Mydriatic Eyedrops Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Mydriatic Eyedrops Players: Market Share by Revenue in 2023
Figure 20. Mydriatic Eyedrops Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Mydriatic Eyedrops Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Mydriatic Eyedrops Sales Market Share by Country (2019-2030)
Figure 23. North America Mydriatic Eyedrops Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Mydriatic Eyedrops Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Mydriatic Eyedrops Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Mydriatic Eyedrops Sales Market Share by Country (2019-2030)
Figure 27. Europe Mydriatic Eyedrops Revenue Market Share by Country (2019-2030)
Figure 28. Germany Mydriatic Eyedrops Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Mydriatic Eyedrops Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Mydriatic Eyedrops Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Mydriatic Eyedrops Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Mydriatic Eyedrops Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Mydriatic Eyedrops Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Mydriatic Eyedrops Revenue Market Share by Region (2019-2030)
Figure 35. China Mydriatic Eyedrops Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Mydriatic Eyedrops Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Mydriatic Eyedrops Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Mydriatic Eyedrops Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Mydriatic Eyedrops Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Taiwan Mydriatic Eyedrops Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Mydriatic Eyedrops Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Mydriatic Eyedrops Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Mydriatic Eyedrops Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Philippines Mydriatic Eyedrops Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Mydriatic Eyedrops Sales Market Share by Country (2019-2030)
Figure 46. Latin America Mydriatic Eyedrops Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Mydriatic Eyedrops Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Mydriatic Eyedrops Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Mydriatic Eyedrops Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Mydriatic Eyedrops Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Mydriatic Eyedrops Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Mydriatic Eyedrops Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Mydriatic Eyedrops Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Mydriatic Eyedrops Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Mydriatic Eyedrops by Type (2019-2030)
Figure 56. Global Revenue Market Share of Mydriatic Eyedrops by Type (2019-2030)
Figure 57. Global Mydriatic Eyedrops Price (USD/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of Mydriatic Eyedrops by Application (2019-2030)
Figure 59. Global Revenue Market Share of Mydriatic Eyedrops by Application (2019-2030)
Figure 60. Global Mydriatic Eyedrops Price (USD/Unit) by Application (2019-2030)
Figure 61. Mydriatic Eyedrops Value Chain
Figure 62. Mydriatic Eyedrops Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
